Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

Lithuania has acquired a batch of small uncrewed aerial systems (UAS) from the US defence supplier, AeroVironment, and ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.

ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.